Previously treated cases tested for RR-/MDR-TB (%) in Cuba
Cuba: Previously treated cases tested for RR-/MDR-TB was 61.0% in 2024. ▲ Rising
Latest (2024)
61.0%
Change on year
up 96.8%
World rank
136th
of 180 countries
All-time high
100.0%
in 2011
All-time low
10.0%
in 2006
Years of data
20
2005–2024
Previously treated cases tested for RR-/MDR-TB in Cuba, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Cuba is 61.0%, measured in 2024.
The figure is up 96.8% on the previous year and down 29.1% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Cuba peaked at 100.0% in 2011 and was at its lowest, 10.0%, in 2006.
That places Cuba 136th out of 180 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Cuba, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 39.0% | — |
| 2006 | 10.0% | -74.4% |
| 2007 | 24.0% | +140.0% |
| 2008 | 55.0% | +129.2% |
| 2009 | 37.0% | -32.7% |
| 2010 | 55.0% | +48.6% |
| 2011 | 100.0% | +81.8% |
| 2012 | 85.0% | -15.0% |
| 2013 | 79.0% | -7.1% |
| 2014 | 86.0% | +8.9% |
| 2015 | 42.0% | -51.2% |
| 2016 | 44.0% | +4.8% |
| 2017 | 52.0% | +18.2% |
| 2018 | 83.0% | +59.6% |
| 2019 | 76.0% | -8.4% |
| 2020 | 59.0% | -22.4% |
| 2021 | 51.0% | -13.6% |
| 2022 | 65.0% | +27.5% |
| 2023 | 31.0% | -52.3% |
| 2024 | 61.0% | +96.8% |
Cuba compared with similar countries
- Cuba's 61.0% is below the median for upper middle income countries, which is 92.0%, 66% of the median. (52 countries reporting)
- Cuba's 61.0% is below the median for Latin America & Caribbean, which is 85.0%, 72% of the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.0% | 10.0% | 55.0% | 5 |
| 2010s | 70.2% | 42.0% | 100.0% | 10 |
| 2020s | 53.4% | 31.0% | 65.0% | 5 |
Countries ranked near Cuba
- 134 Madagascar 69.0% compare
- 135 Costa Rica 62.0% compare
- 136 Panama 61.0% compare
- 136 Argentina 61.0% compare
- 136 Austria 61.0% compare
More health data for Cuba
- Un projection of annual infant deaths, annual growth rate -1.47 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2059 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,696 deaths per 1,000 people (2090)
- Number of infants who die before age 1 67 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.64 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2020)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Cuba?
- Previously treated cases tested for rr-/mdr-tb in Cuba was 61.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Cuba?
- The highest recorded value was 100.0% in 2011.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Cuba?
- The lowest recorded value was 10.0% in 2006.
- How does Cuba rank for previously treated cases tested for rr-/mdr-tb?
- Cuba ranks 136th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Cuba?
- Over the last ten years it is down 29.1%. The long-run trend across the full record is rising.
- Where does this Cuba data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).